Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Sell
Relative Strength Index
Neutral
Standard Deviation
Neutral
Williams %R
Strong Buy
Average Directional Index
Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Sell
C
Windtree Therapeutics, Inc. Common Stock (WINT)
Biological Products, (no Disgnostic Substances)
Windtree Therapeutics Inc is a development-stage biotechnology company focused on developing KL4 surfactant therapies for respiratory diseases. Its technology platform includes synthetic, peptide-containing surfactant and novel drug-delivery technologies that deliver aerosolized KL4 surfactants without invasive procedures. Its development program utilizing its proprietary technology platform is AEROSURF which is being developed for the treatment of respiratory distress syndrome in premature infants. It operates in the business segment of research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products.
2600 KELLY ROAD, SUITE 100
WARRINGTON, PA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
01/25/1984
Market Cap
6,458,911
Shares Outstanding
6,510,000
Weighted SO
6,507,864
Total Employees
N/A
Upcoming Earnings
08/05/2024
Similar Tickers
Beta
0.5560
Last Div
0.0000
Range
2.81-27.0
Chg
-0.2280
Avg Vol
940438
Mkt Cap
6458911
Exch
NASDAQ
Country
US
Phone
215 488 9300
DCF Diff
14.3628
DCF
-3.2278
Div Yield
0.0000
P/S
0.0000
EV Multiple
-0.3030
P/FV
0.3290
Div Yield %
0.0000
P/E
-0.8512
PEG
-0.0093
Payout
0.0000
Current Ratio
0.6698
Quick Ratio
0.6698
Cash Ratio
0.5109
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
3482.9661
CCC
0.0000
Gross Margin
0.0000
Op Margin
0.0000
Pretax Margin
0.0000
Net Margin
0.0000
Eff Tax Rate
-0.0419
ROA
-0.1980
ROE
-0.6291
ROCE
-0.8285
NI/EBT
1.0195
EBT/EBIT
0.2810
EBIT/Rev
0.0000
Debt Ratio
0.0493
D/E
0.0962
LT Debt/Cap
0.0631
Total Debt/Cap
0.0878
Int Coverage
-408.0588
CF/Debt
-9.3430
Equity Multi
1.9521
Rec Turnover
0.0000
Pay Turnover
0.1048
Inv Turnover
0.0000
FA Turnover
0.0000
Asset Turnover
0.0000
OCF/Share
-29.8175
FCF/Share
-29.8497
Cash/Share
5.4775
OCF/Sales
0.0000
FCF/OCF
1.0011
CF Coverage
-9.3430
ST Coverage
-31.0874
CapEx Coverage
-924.3333
Div&CapEx Cov
-924.3333
P/BV
0.3290
P/B
0.3290
P/S
0.0000
P/E
-0.8512
P/FCF
-0.4653
P/OCF
-0.3660
P/CF
-0.3660
PEG
-0.0093
P/S
0.0000
EV Multiple
-0.3030
P/FV
0.3290
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
5.43K Shares Bought (99.98 %)
0.00 Shares Sold (0.02%)
9 - 12 Months
6.72K Shares Bought (99.99 %)
0.00 Shares Sold (0.01 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 304.00K | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 135.00K | ▼ 22.00K | ▼ 21.00K |
Gross Profit | 304.00K | ▼ 0.00 | 0.00 | 0.00 | ▼ -135.00K | ▲ -22.00K | ▲ -21.00K |
Gross Profit Ratio | 1.00 | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research And Development Expenses | 2.37M | ▼ 2.14M | ▲ 3.54M | ▲ 4.48M | ▼ 1.22M | ▲ 3.03M | ▼ 2.23M |
General And Administrative Expenses | 2.79M | ▼ 2.41M | ▲ 3.43M | ▼ 2.97M | ▼ 2.24M | ▼ 1.91M | ▲ 2.15M |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling General And Administrative Expenses | 2.79M | ▼ 2.41M | ▲ 3.43M | ▼ 2.97M | ▼ 2.24M | ▼ 1.91M | ▲ 2.15M |
Other Expenses | -85.00K | ▼ -919.00K | ▲ -496.00K | ▲ -24.00K | ▼ -286.00K | ▲ -244.00K | ▲ 201.00K |
Operating Expenses | 5.16M | ▼ 4.55M | ▲ 6.96M | ▲ 7.44M | ▼ 3.46M | ▲ 4.94M | ▼ 4.38M |
Cost And Expenses | 5.16M | ▼ 4.55M | ▲ 6.96M | ▲ 7.44M | ▼ 3.46M | ▲ 4.96M | ▼ 4.41M |
Interest Income | 6.00K | ▲ 29.00K | ▼ 7.00K | ▼ 1.00K | ▲ 52.00K | ▲ 61.00K | ▼ 30.00K |
Interest Expense | 767.00K | ▼ 137.00K | ▼ 4.00K | ▲ 13.00K | 13.00K | ▼ 12.00K | ▲ 13.00K |
Depreciation And Amortization | 38.00K | ▼ -724.00K | ▲ 42.00K | ▲ 52.00K | ▲ 7.12M | ▼ 22.00K | ▼ 21.00K |
Ebitda | -8.24M | ▲ -2.76M | ▼ -7.41M | ▼ -7.47M | ▲ -3.69M | ▼ -4.94M | ▲ -4.38M |
Ebitda Ratio | -27.10 | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Income | -4.85M | ▲ -4.55M | ▼ -6.96M | ▼ -14.69M | ▲ -10.81M | ▲ -4.96M | ▲ -4.41M |
Operating Income Ratio | -15.96 | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Other Income Expenses Net | -3.43M | ▲ -1.79M | ▲ -496.00K | ▼ -7.27M | ▲ -247.00K | ▲ -195.00K | ▲ 14.74M |
Income Before Tax | -9.04M | ▲ -7.38M | ▼ -7.45M | ▼ -14.73M | ▲ -11.06M | ▲ -5.15M | ▲ 10.33M |
Income Before Tax Ratio | -29.74 | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Tax Expense | -2.66M | ▲ 3.55M | ▼ -492.00K | ▼ -1.66M | ▲ -1.37M | ▲ 0.00 | ▲ 114.00K |
Net Income | -9.04M | ▲ -7.38M | ▼ -7.45M | ▼ -13.07M | ▲ -9.69M | ▲ -5.15M | ▲ 10.22M |
Net Income Ratio | -29.74 | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Eps | -0.84 | ▼ -31.98 | ▲ -0.42 | ▼ -0.49 | ▼ -15.38 | ▲ -1.33 | ▲ 21.98 |
Eps Diluted | -0.84 | ▼ -31.98 | ▲ -0.42 | ▼ -0.49 | ▼ -15.38 | ▲ -1.33 | ▲ 21.98 |
Weighted Average Shs Out | 214.22K | ▲ 230.65K | ▲ 338.64K | ▲ 563.04K | ▲ 630.00K | ▲ 3.88M | ▼ 465.00K |
Weighted Average Shs Out Dil | 214.22K | ▲ 230.65K | ▲ 338.64K | ▲ 563.04K | ▲ 630.00K | ▲ 3.88M | ▼ 465.00K |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 11.19M | ▲ 22.58M | ▼ 16.93M | ▲ 22.35M | ▼ 6.17M | ▼ 4.32M | ▼ 2.55M |
Short Term Investments | 13.96M | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash And Short Term Investments | 25.15M | ▼ 22.58M | ▼ 16.93M | ▲ 22.35M | ▼ 6.17M | ▼ 4.32M | ▼ 2.55M |
Net Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Current Assets | 507.00K | ▲ 1.28M | ▼ 1.19M | ▼ 1.14M | ▲ 1.21M | ▼ 1.06M | ▼ 792.00K |
Total Current Assets | 25.65M | ▼ 23.86M | ▼ 18.12M | ▲ 23.49M | ▼ 7.38M | ▼ 5.38M | ▼ 3.34M |
Property Plant Equipment Net | 802.00K | ▲ 2.19M | ▼ 1.84M | ▲ 3.39M | ▼ 2.12M | ▼ 1.63M | ▼ 1.51M |
Goodwill | 15.68M | 15.68M | 15.68M | 15.68M | ▼ 3.06M | ▼ 0.00 | 0.00 |
Intangible Assets | 77.09M | 77.09M | 77.09M | ▼ 32.07M | ▼ 25.25M | 25.25M | 25.25M |
Goodwill And Intangible Assets | 92.77M | 92.77M | 92.77M | ▼ 47.75M | ▼ 28.31M | ▼ 25.25M | 25.25M |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 154.00K | ▼ 150.00K | ▼ 9.00K |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -154.00K | ▲ -150.00K | ▲ -9.00K |
Other Non Current Assets | 171.00K | ▼ 154.00K | 154.00K | 154.00K | 154.00K | ▼ 150.00K | ▼ 9.00K |
Total Non Current Assets | 93.75M | ▲ 95.11M | ▼ 94.77M | ▼ 51.30M | ▼ 30.58M | ▼ 27.03M | ▼ 26.76M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 119.40M | ▼ 118.98M | ▼ 112.89M | ▼ 74.79M | ▼ 37.95M | ▼ 32.41M | ▼ 30.10M |
Account Payables | 3.42M | ▼ 1.71M | ▼ 1.16M | ▼ 693.00K | ▼ 249.00K | ▲ 809.00K | ▲ 1.69M |
Short Term Debt | 7.97M | ▼ 911.00K | ▲ 1.16M | ▼ 822.00K | ▼ 656.00K | ▲ 669.00K | ▼ 446.00K |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 198.00K | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Current Liabilities | 9.04M | ▼ 5.20M | ▼ 3.81M | ▼ 3.41M | ▼ 1.55M | ▲ 2.52M | ▲ 2.85M |
Total Current Liabilities | 20.63M | ▼ 7.82M | ▼ 6.13M | ▼ 4.92M | ▼ 2.46M | ▲ 4.00M | ▲ 4.99M |
Long Term Debt | 0.00 | ▲ 5.40M | ▼ 2.62M | ▼ 2.07M | ▼ 1.62M | ▲ 15.00M | ▼ 1.04M |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.16M | ▼ 0.00 |
Deferred Tax Liabilities Non Current | 15.48M | ▲ 15.82M | ▲ 16.78M | ▼ 7.11M | ▼ 5.06M | ▼ 5.06M | ▼ 4.86M |
Other Non Current Liabilities | 15.18M | ▼ 15.00M | ▲ 17.80M | ▲ 18.80M | 18.80M | ▼ 3.80M | 3.80M |
Total Non Current Liabilities | 30.65M | ▲ 36.22M | ▲ 37.20M | ▼ 27.99M | ▼ 25.49M | ▼ 25.02M | ▼ 9.70M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Lease Obligations | 0.00 | ▲ 1.54M | ▼ 1.01M | ▲ 2.60M | ▼ 2.03M | ▼ 1.16M | ▼ 1.04M |
Total Liabilities | 51.28M | ▼ 44.04M | ▼ 43.33M | ▼ 32.91M | ▼ 27.94M | ▲ 29.02M | ▼ 14.68M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 32.00K | ▲ 41.00K | ▼ 17.00K | ▲ 28.00K | ▼ 0.00 | ▲ 6.00K | ▼ 1.00K |
Retained Earnings | -657.65M | ▼ -685.12M | ▼ -717.69M | ▼ -785.32M | ▼ -824.53M | ▼ -844.82M | ▲ -834.60M |
Accumulated Other Comprehensive Income Loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Total Stockholders Equity | 725.73M | ▲ 760.02M | ▲ 787.22M | ▲ 827.18M | ▲ 834.54M | ▲ 848.21M | ▲ 850.02M |
Total Stockholders Equity | 68.11M | ▲ 74.94M | ▼ 69.55M | ▼ 41.88M | ▼ 10.01M | ▼ 3.39M | ▲ 15.42M |
Total Equity | 68.11M | ▲ 74.94M | ▼ 69.55M | ▼ 41.88M | ▼ 10.01M | ▼ 3.39M | ▲ 15.42M |
Total Liabilities And Stockholders Equity | 119.40M | ▼ 118.98M | ▼ 112.89M | ▼ 74.79M | ▼ 37.95M | ▼ 32.41M | ▼ 30.10M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 119.40M | ▼ 118.98M | ▼ 112.89M | ▼ 74.79M | ▼ 37.95M | ▼ 32.41M | ▼ 30.10M |
Total Investments | 13.96M | ▼ 0.00 | 0.00 | 0.00 | ▲ 154.00K | ▼ 150.00K | ▼ 9.00K |
Total Debt | 7.97M | ▼ 6.31M | ▼ 3.78M | ▼ 2.89M | ▼ 2.28M | ▲ 16.83M | ▼ 1.48M |
Net Debt | -3.21M | ▼ -16.27M | ▲ -13.15M | ▼ -19.46M | ▲ -3.89M | ▲ 12.51M | ▼ -1.06M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -9.04M | ▲ -7.38M | ▼ -7.45M | ▼ -13.07M | ▲ -9.69M | ▲ -5.15M | ▲ 10.22M |
Depreciation And Amortization | 38.00K | ▼ -724.00K | ▲ 42.00K | ▲ 52.00K | ▼ 24.00K | ▼ 22.00K | ▼ 21.00K |
Deferred Income Tax | 3.35M | ▼ 1.79M | ▼ 1.14M | ▼ -1.66M | ▲ -1.37M | ▲ -485.00K | ▲ 0.00 |
Stock Based Compensation | 252.00K | ▲ 1.51M | ▼ 1.28M | ▲ 1.62M | ▼ 791.00K | ▼ 306.00K | ▼ 251.00K |
Change In Working Capital | -1.35M | ▼ -1.62M | ▲ 512.00K | ▲ 635.00K | ▼ -832.00K | ▲ 901.00K | ▲ 1.19M |
Accounts Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payables | -474.00K | ▲ 345.00K | ▲ 435.00K | ▼ 111.00K | ▼ -161.00K | ▲ -135.00K | ▲ 880.00K |
Other Working Capital | -871.00K | ▼ -1.97M | ▲ 77.00K | ▲ 524.00K | ▼ -671.00K | ▲ 1.04M | ▼ 310.00K |
Other Non Cash Items | 560.00K | ▲ 953.00K | ▼ -62.00K | ▲ 7.49M | ▲ 7.70M | ▼ 843.00K | ▼ -15.22M |
Net Cash Provided By Operating Activities | -6.19M | ▲ -5.46M | ▲ -4.54M | ▼ -4.93M | ▲ -3.38M | ▼ -3.57M | ▲ -2.95M |
Investments In Property Plant And Equipment | 0.00 | ▼ -62.00K | ▼ -264.00K | ▲ -173.00K | ▲ 0.00 | 0.00 | 0.00 |
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Purchases Of Investments | -13.96M | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sales Maturities Of Investments | 0.00 | ▼ -75.00K | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 223.00K | ▼ 75.00K | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash Used For Investing Activities | -13.74M | ▲ -62.00K | ▼ -264.00K | ▲ -173.00K | ▲ 0.00 | 0.00 | 0.00 |
Debt Repayment | 0.00 | ▼ -1.24M | ▲ -352.00K | ▼ -441.00K | ▲ -377.00K | ▲ -234.00K | ▲ -233.00K |
Common Stock Issued | 30.35M | ▼ 0.00 | ▲ 20.25M | ▼ 3.15M | ▼ 1.49M | ▼ 755.00K | ▲ 1.37M |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 65.00K | ▲ 23.98M | ▼ -19.85M | ▲ 200.00K | ▲ 1.49M | ▼ 755.00K | ▲ 1.27M |
Net Cash Used Provided By Financing Activities | 30.42M | ▼ 22.74M | ▼ 48.00K | ▲ 2.91M | ▼ 1.12M | ▼ 521.00K | ▲ 1.03M |
Effect Of Forex Changes On Cash | 88.00K | ▲ 923.00K | ▼ -671.00K | ▲ 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash | 10.58M | ▲ 18.14M | ▼ -5.43M | ▲ -2.19M | ▼ -2.26M | ▼ -3.05M | ▲ -1.77M |
Cash At End Of Period | 11.36M | ▲ 22.73M | ▼ 17.08M | ▲ 22.50M | ▼ 6.33M | ▼ 4.32M | ▼ 2.55M |
Cash At Beginning Of Period | 780.00K | ▲ 4.59M | ▲ 22.51M | ▲ 24.70M | ▼ 8.59M | ▼ 7.37M | ▼ 4.32M |
Operating Cash Flow | -6.19M | ▲ -5.46M | ▲ -4.54M | ▼ -4.93M | ▲ -3.38M | ▼ -3.57M | ▲ -2.95M |
Capital Expenditure | 0.00 | ▼ -62.00K | ▼ -264.00K | ▲ -173.00K | ▲ 0.00 | 0.00 | 0.00 |
Free Cash Flow | -6.19M | ▲ -5.52M | ▲ -4.80M | ▼ -5.11M | ▲ -3.38M | ▼ -3.57M | ▲ -2.95M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)